| Identification | Back Directory | [Name]
DOTA | [CAS]
60239-18-1 | [Synonyms]
DOTA
NSC 681107
TETRAXETAN
DOTA(M-140)
TetraxetanuM
Tetraxetan/radical
Tetraxetanum (DOTA)
TETRAAZA-12-CROWN-4-1,4,7,10-TETRAACETIC ACID
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID
1,4,7,10-Tetraazacyclododecan-N,N',N,N'-tetraacetic acid
4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrakisacetic acid
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID DOTA
TETRAAZA-12-CROWN-4 TETRAACETIC ACID AMMONIUM SALT (SEE 2923)
1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETIC ACID
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID, FREE ACID
1,4,7,10-TETRAAZACYCLODODECANE-N,N'',N , N''-TETRAACETIC ACID , (DOTA)
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid >=97.0% (CHN)
1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraaceticacid,min.98%DOTA
Tetraxetan/DOTA/1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid
2,2',2'',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic acid
2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid
2,2',2'',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetryl)tetrakisacetic acid
2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane
-1,4,7,10-tetrayl)tetraacetic acid(DOTA)
DOTA Tetraxetan 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid | [EINECS(EC#)]
611-959-5 | [Molecular Formula]
C16H28N4O8 | [MDL Number]
MFCD00068657 | [MOL File]
60239-18-1.mol | [Molecular Weight]
404.42 |
| Chemical Properties | Back Directory | [Appearance]
Colourless crystals | [Melting point ]
267 °C | [Boiling point ]
701.6±60.0 °C(Predicted) | [density ]
1.321 | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
Water (Slightly, Heated), Methanol (Slightly) | [form ]
Powder | [pka]
2.16±0.10(Predicted) | [color ]
white | [BRN ]
1186987 | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Chemical Properties]
Colourless crystals | [Uses]
Bifunctional DOTA aconjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and ther
apeutic radiopharmaceuticals. | [Definition]
ChEBI: An azamacrocyle in which four nitrogen atoms at positions 1, 4, 7 and 10 of a twelve-membered ring are each substituted with a carboxymethyl group. |
|
|